| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9571 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.6675 |
| P-glycoprotein Substrate | Non-substrate | 0.5119 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6462 |
| Non-inhibitor | 0.7801 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6858 |
| Distribution |
| Subcellular localization | Lysosome | 0.7074 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7342 |
| CYP450 2D6 Substrate | Substrate | 0.8358 |
| CYP450 3A4 Substrate | Substrate | 0.6105 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7740 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9072 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6370 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.6572 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5428 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7265 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9286 |
| Inhibitor | 0.7779 |
| AMES Toxicity | AMES toxic | 0.5335 |
| Carcinogens | Non-carcinogens | 0.8282 |
| Fish Toxicity | High FHMT | 0.9912 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9979 |
| Honey Bee Toxicity | Low HBT | 0.7383 |
| Biodegradation | Not ready biodegradable | 0.9735 |
| Acute Oral Toxicity | III | 0.4643 |
| Carcinogenicity (Three-class) | Non-required | 0.7642 |